Skip to main content

HIV Infection News

Related terms: Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency Syndrome (AIDS), Acute HIV Infection, Acute Retroviral Syndrome, AIDS, AIDS-Related Complex, Chronic Symptomatic HIV Infection, HIV Infection, Acute, HIV Seroconversion Syndrome, Human Immunodeficiency Virus Infection, Primary HIV Infection, HIV, ARC, Acquired Immunodeficiency Syndrome, HIV/AIDS

GLP-1 RA Reduces Severity of Steatotic Liver Disease in People With HIV

MONDAY, March 18, 2024 – For people with HIV (PWH) with metabolic-associated steatotic liver disease (MASLD), semaglutide is associated with absolute and relative declines in intrahepatic...

High Rate of PrEP Discontinuation Seen for Sexual Gender-Minority People

THURSDAY, March 14, 2024 – Among sexual and gender-minority people who initiate preexposure prophylaxis (PrEP) for HIV, the annual rate of discontinuation is between 35 and 40 percent, according to...

Dapivirine Vaginal Ring Safe, Effective at Preventing HIV During Pregnancy

THURSDAY, March 14, 2024 – Adverse pregnancy outcomes related to use of the dapivirine vaginal ring (DVR) or daily oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) during the second...

Children Can Remain HIV-Free After Pause in Antiretroviral Therapy

WEDNESDAY, March 13, 2024 – Very early treatment of in utero HIV-1 can result in antiretroviral therapy (ART)-free remission for ≥48 weeks, according to a study presented at the annual Conference on ...

Long-Acting Injectable ART Superior to Standard Care for Poorly Adherent People With HIV

TUESDAY, March 12, 2024 – For people with HIV (PWH) and a history of suboptimal adherence to antiretroviral therapy, long-acting injectable treatment with cabotegravir and rilpivirine (LAI) is...

Nurse-Led Strategy Reduces Cardiovascular Risk Factors for People With HIV

MONDAY, March 11, 2024 – Nurse-led management can lower cardiovascular risk factors among individuals with HIV receiving antiretroviral therapy, according to a study published online March 5 in JAMA ...

Early Treatment Can Push HIV Into Remission in Kids: Study

FRIDAY, March 8, 2024 – Ever since one child, dubbed the 'Mississippi baby,' went into drug-free remission of HIV in 2013, experts have wondered if giving treatment within hours of birth might do...

Ozempic Eases Fatty Liver Disease in People Living With HIV

THURSDAY, March 7, 2024 – There's more good news around the diabetes and weight-loss drug Ozempic: It might help ease fatty liver disease in people living with HIV, new research shows. Six months of...

Drug-Emitting Vaginal Ring Safely Protects Pregnant Women From HIV

WEDNESDAY, March 6, 2024 – A vaginal ring that emits the antiviral dapivirine has passed safety trials and could shield vulnerable women against HIV infection during pregnancy, a new trial shows....

Mixed Digital Intervention Increases HIV Prevention Adherence in Young People

TUESDAY, March 5, 2024 – A synergistic effect is seen for multimodal strategies to improve uptake of and adherence to HIV prevention among young people at risk for acquisition, according to a study...

High Number of People on HIV-Preventing PrEP Stop Using It

TUESDAY, March 5, 2024 – Many people protected by drugs that prevent HIV infection quit using them, upping their vulnerability to the virus that causes AIDS, new research shows. The drug combo known...

U.S. FDA Approves Expanded Indication for Gilead’s Biktarvy to Treat People with HIV with Suppressed Viral Loads, Pre-Existing Resistance

FOSTER CITY, Calif.--(BUSINESS WIRE) February 26, 2024 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced the U.S. Food and Drug Administration (FDA) approved a new, expanded indication for...

People With Intellectual, Developmental Disabilities Experience HIV Disparities

FRIDAY, Feb. 23, 2024 – Disparities across the HIV care continuum exist for people with intellectual and developmental disabilities (IDDs), according to a study published in the February issue of...

Accelerated Epigenetic Aging Seen in Women With HIV

THURSDAY, Feb. 22, 2024 – Accelerated epigenetic aging is seen in women with HIV versus women without HIV, according to a study published online Feb. 15 in the Journal of Infectious Diseases. ...

Women With HIV Age Faster, Study Shows

FRIDAY, Feb. 16, 2024 – Women with HIV experience accelerated DNA aging, potentially leading to poorer physical function sooner in life than expected, a new study says. Markers of aging measured in...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Pre-Exposure Prophylaxis, Viral Infection

Related drug support groups

Biktarvy, bictegravir / emtricitabine / tenofovir alafenamide, Genvoya, Triumeq